Difference between revisions of "IPS Appendix 1"

From HL7 IPS
Jump to: navigation, search
(→‎Appendix)
 
(27 intermediate revisions by 4 users not shown)
Line 2: Line 2:
  
 
==Acronyms and abbreviations ==
 
==Acronyms and abbreviations ==
−
 
+
*'''CCD''': Continuity of Care Document
−
'''CCD''' Continuity of Care Document
+
*'''C-CDA''': Consolidated CDA
−
<br/>'''C-CDA''' Consolidated CDA
+
*'''CDA''': Clinical Document Architecture
−
<br/>'''CDA''' Clinical Document Architecture
+
*'''CEN''': Comité Européen de Normalisation (European Committee for Standardization)
−
<br/>'''CEN''' Comité Européen de Normalisation (European Committee for Standardization)
+
*'''CEN/TC&nbsp;251 ''': CEN Technical Committe 251
−
<br/>'''CEN/TC 251 ''' CEN Technical Committe 251
+
*'''DSTU''': Draft Standard for Trial Use
−
<br/>'''DSTU''' Draft Standard for Trial Use
+
*'''EC''': European Commission
−
<br/>'''EC''' European Commission
+
*'''EDQM''': European Directorate for the Quality of Medicines &amp; Healthcare
−
<br/>'''EDQM''' European Directorate for the Quality of Medicines & Healthcare
+
*'''eHDSI''': Digital Service Infrastructure for eHealth
−
<br/>'''eHDSI''' Digital Service Infrastructure for eHealth
+
*'''eHN''': eHealth Network
−
<br/>'''eHN''' eHealth Network
+
*'''EHR''': Electronic Healthcare Record
−
<br/>'''EHR''' Electronic Healthcare Report
+
*'''EN''': European Normative [or Standard] (CEN)
−
<br/>'''EN''' European Normative [or Standard] (CEN)
+
*'''epSOS''': European Patient Smart Open Services
−
<br/>'''epSOS''' European Patient Smart Open Services
+
*'''EU''': European; Europe
−
<br/>'''EU''' European; Europe
+
*'''FDA''': Food and Drug Administration (USA)
−
<br/>'''FDA''' Food and Drug Administration (USA)
+
*'''GP''': General Practitioner
−
<br/>'''GP''' General Practitioner
+
*'''HL7''': Health Level Seven
−
<br/>'''HL7''' Health Level Seven
+
*'''HP''': Healthcare Professional
−
<br/>'''HP''' Healthcare Professional
+
*'''IDMP''': IDentification of Medicinal Products (ISO Standard)
−
<br/>'''IDMP''' IDentification of Medicinal Products (ISO Standard)
+
*'''IHE''': Integrating the Healthcare Enterprise
−
<br/>'''IHE''' Integrating the Healthcare Enterprise
+
*'''INTERPAS''': International Patient Summary (HL7 International Project)
−
<br/>'''INTERPAS''' International Patient Summary (HL7 International Project)
+
*'''IPS''': International Patient Summary
−
<br/>'''IPS''' International Patient Summary
+
*'''ISO''': International Organization for Standardization
−
<br/>'''ISO''' International Organization for Standardization
+
*'''JAseHN''': Joint Action to Support the eHealth Network
−
<br/>'''JAseHN''' Joint Action to Support the eHealth Network
+
*'''JIC''': Joint Initiative Council on SDO Global Health Informatics Standardization
−
<br/>'''JIC''' Joint Initiative Council on SDO Global Health Informatics Standardization
+
*'''LOINC''': Logical Observation Identifiers Names &amp; Codes
−
<br/>'''LOINC''' Logical Observation Identifiers Names & Codes
+
*'''MOU''': Memorandum of Understanding (on cooperation surrounding health related information and communication technologies, that between EU and US)
−
<br/>'''MOU''' Memorandum of Understanding (on cooperation surrounding health related information and communication technologies, that between EU and US)  
+
*'''MPID''': Medicinal Product Identifier  
−
<br/>'''MPID''' Medicinal Product Identifier  
+
*'''ONC''': Office of the National Coordinator for Health Information Technology (USA)
−
<br/>'''ONC''' Office of the National Coordinator for Health Information Technology (USA)
+
*'''PCC''': Patient Care Coordination
−
<br/>'''PCC''' Patient Care Coordination
+
*'''PCID ''': Medicinal Product Package Identifier
−
<br/>'''PCID ''' Medicinal Product Package Identifier
+
*'''PhPID(s)''': Pharmaceutical Product Identifier(s)
−
<br/>'''PhPID(s)''' Pharmaceutical Product Identifier(s)
+
*'''prEN''': Draft European Normative [or Standard] (CEN)
−
<br/>'''prEN''' Draft European Normative [or Standard] (CEN)
+
*'''prTS''': Draft Technical Specifications (CEN)
−
<br/>'''prTS''' Draft Technical Specifications (CEN)
+
*'''PS''': Patient Summary
−
<br/>'''PS''' Patient Summary
+
*'''S&I''': Standards and Interoperability (S&I) Framework (run by ONC)
−
<br/>'''S&I''' Standards and Interoperability (S&I) Framework (run by ONC)
+
*'''SAIF''': Service Aware Interoperability Framework
−
<br/>'''SAIF''' Service Aware Interoperability Framework
+
*'''SDO''': Standards Developing Organization
−
<br/>'''SDO''' Standard Developing Organization
+
*'''STU''': Standard for Trial Use
−
<br/>'''STU''' Standard for Trial Use
+
*'''TS''': Technical Specifications (CEN)
−
<br/>'''TB''' Trillium Bridge
+
*'''UCUM''': Unified Code for Units of Measure
−
<br/>'''TS''' Technical Specifications (CEN)
+
*'''WHO''': World Health Organization
−
<br/>'''UCUM''' Unified Code for Units of Measure
 
−
<br/>'''WHO''' World Health Organization
 
  
 
==Glossary ==
 
==Glossary ==
 +
*'''Compliance.'''  A standard or specification is compliant with another standard or specification if all propositions that are true in the initial standard are also true in the complying standard. The target artifact is compliant with the source artifact if and only if all conforming implementations of the target are also conforming with the source (RM-ODP). The term compliance is also used to state expectations as to how certain specifications need to satisfy possible legislative or regulatory constraints or requirements.
 +
*'''Conformance''' relates an implementation to a standard. Any proposition that is true of the specification must be true in its implementation. (ISO, 2010).
 +
*'''Conformance Assessment''' is a process whereby a given implementation instance is evaluated to determine which of its various Conformance Assertions are valid implementations of a given specification’s Conformance Statements.
 +
*'''Conformance Statement''' is a statement that identifies testable requirements at a specified Conformance Point within a specification, explicitly defining the behavior which must be satisfied at these points. Conformance Statements will only occur in standard which are intended to constrain some feature of a real implementation, so that there exists, in principle, the possibility of testing.
 +
*'''Conformance Assertion''' is a testable, verifiable statement made about a specific implementation instance against a corresponding Conformance Statement.
 +
*'''Conformance Points''' are the evaluation of conformance at specific points in the implementation or specification. See Conformance.
 +
*  '''Electronic Patient Summary''': electronic health record extract containing essential healthcare information intended for specific uses . (EN ISO 13940: 2016)
 +
* '''International Patient Summary''' : electronic patient summary for use in the unscheduled, cross-border care scenario comprising at least the required elements of the IPS dataset.
 +
* '''International Patient Summary dataset''': a minimal and non-exhaustive patient summary dataset, specialty-agnostic, condition-independent, but readily usable by clinicians for the cross-border unscheduled care of a patient.
  
−
'''Compliance''': Compliance of one standard or specification is compliant with another standard or specification if all propositions true in the initial standard are also true in the complying standard. The target artifact is compliant with the source artifact if and only if all conformant implementations of the target are also conformant with the source. (RM-ODP). The term compliance is also used to state expectations as to how certain specifications need to satisfy possible legislative or regulatory constraints or requirements.
+
==Real World User Stories==
  
−
'''Conformance''': Conformance relates an implementation to a standard. Any proposition that is true of the specification must be true in its implementation. (ISO, 2010).
+
This section reports a series of real world user stories adapted from the Trillium Bridge project <ref>The Trillium Bridge Project http://www.trilliumbridge.eu</ref> and the eHDSI initiative <ref>The eHDSI initiative https://ec.europa.eu/cefdigital/wiki/display/EHOPERATIONS/eHealth+DSI+Operations+Home</ref>.
  
−
'''Conformance Assessment''': A process whereby a given implementation instance is evaluated to determine which f its various Conformance Assertions are valid implementations of a given specification’s Conformance Statements.
+
=== IPS Storyboard 1: Martha, a traveling corporate executive ===
 +
Martha, a 45-year old corporate executive and breast cancer survivor travels frequently on business between the US and EU countries. She carries a clinical summary on her mobile phone and on paper just in case she needs to seek medical care regarding recurring symptoms. Martha’s summary includes
 +
*Breast cancer Stage II with no evidence of recurrence following treatment
 +
*hot flashes as problems
 +
*Anastrozole 1 mg. once daily
 +
*Black Cohosh Extract herbal supplement as medications
 +
*the indication of an allergy to Penicillin
 +
*and finally as Plan of Care, to continue hormone medication with Anastrozole for total of 5 years
 +
*and monitor for potential breast cancer recurrence.  
  
−
'''Conformance Statement''' : A conformance Statement is a statement that identifies testable requirements at a specified Conformance Point within a specification, explicitly defining the behavior which must be satisfied at these points. Conformance Statements will only occur in standard which are intended to constrain some feature of a real implementation, so that there exists, in principle, the possibility of testing.
+
During a visit in Austria, Martha walks up a hill and experiences shortness of breath, faints, and wakes up a few minutes later after hitting her head on a stone step. A passerby helps her get to the emergency department of a local hospital. An ambulance is called and she is brought to the emergency ward.
  
−
'''Conformance assertion''': Conformance assertion is a testable, verifiable statement made about a specific implementation instance against a corresponding Conformance Statement.
+
During registration and admission, Martha hands in her patient summary in a USB key.  At the hospital, Martha is evaluated by an oncologist and a cardiologist.
  
−
'''Conformance points''': Conformance points are the evaluation of conformance at specific points in the implementation or specification. See Conformance.
+
Following care provision, Martha receives an encounter report. When back home she hands in the encounter report to her primary physician, who updates her record.
  
−
== Real World User Stories ==
+
=== IPS Storyboard 2: Paolo, a retired businessman ===
 +
Paolo Cerruti is a 67-year-old retired businessman, who normally lives in the outskirts Bergamo, near Lake Como, in Lombardy. He is generally healthy, but has long-standing hypertension. His regular physician changed his medication two weeks ago because of poor blood pressure control on his previous medication. He is on holiday going through New England, US, travelling on his own to enjoy the autumn foliage, and is presently in Boston, MA. He is nearing the end of his holiday, and will be returning to Italy in three days’ time.  Two days ago he lost his day bag. The bag included his hypertension medication, and he has not been able to take his tablets for two days.
  
−
This section reports a series of real world user stories adapted from the Trillium Bridge project <ref>The Trillium Bridge Project http://www.trilliumbridge.eu</ref> and the eHDSI initiative <ref>The eHDSI initiative https://ec.europa.eu/cefdigital/wiki/display/EHOPERATIONS/eHealth+DSI+Operations+Home. </ref>
+
This morning he has woken up feeling dizzy and has blurred vision. The hotel is able to put him in urgent contact with a local general practitioner (GP). Having assessed him, the GP noted a raised blood pressure, but is uncertain about whether to attribute these symptoms to the raised blood pressure or a side effect of the new medication. Now, the GP in Boston needs to know the medication, and the past few blood pressure readings to determine how exceptional the present reading is and manage Paolo appropriately.  
  
−
=== Martha a traveling corporate executive ===
+
Immediate access to his International Patient Summary would be the perfect answer. Paolo may retrieve his online European Patient Summary for emergency access that is retrieved, transformed into an IPS and shown its content translated in English.
−
Martha, a 45-year old corporate executive and breast cancer survivor travels frequently on business between the US and EU countries. She carries a clinical summary on her mobile phone and on paper just in case she needs to seek medical care regarding recurring symptoms. Martha’s summary includes Breast cancer Stage II with no evidence of recurrence following treatment; hot flashes as problems; Anastrozole 1 mg. once daily; Black Cohosh Extract herbal supplement as medications; the indication of an allergy to Penicillin; and finally as Plan of Care, to continue hormone medication with Anastrozole for total of 5 years; and monitor for potential breast cancer recurrence.
 
−
During a visit in Austria, Martha walks up a hill and experiences shortness of breath, faints, and wakes up a few minutes later after hitting her head on a stone step. A passerby helps her get to the emergency department of a local hospital. An ambulance is called and she is brought to the emergency ward.
 
−
During registration and admission, Martha hands in her patient summary in a USB key.  At the hospital, Martha is evaluated by an oncologist and a cardiologist.
 
−
Following care provision, Martha receives an encounter report. When back home she hands in the encounter report to her primary physician, who updates her record.
 
  
−
=== Paolo a retired businessman ===
 
−
Paolo Cerruti is a 67-year-old retired businessman, who normally lives in the outskirts Bergamo, near Lake Como, in Lombardy. He is generally healthy, but has long-standing hypertension. His regular physician changed his medication two weeks ago because of poor blood pressure control on his previous medication. He is on holiday going through New England, US, travelling on his own to enjoy the autumn foliage, and is presently in Boston, MA. He is nearing the end of his holiday, and will be returning to Italy in three days’ time.  Two days ago he lost his day bag. The bag included his hypertension medication, and he has not been able to take his tablets for two days.
 
−
This morning he has woken up feeling dizzy and has blurred vision. The hotel is able to put him in urgent contact with a local general practitioner (GP). Having assessed him, the GP noted a raised blood pressure, but is uncertain about whether to attribute these symptoms to the raised blood pressure or a side effect of the new medication. Now, the GP in Boston needs to know the medication, and the past few blood pressure readings to determine how exceptional the present reading is and manage Paolo appropriately.
 
−
Immediate access to his International Patient Summary  would be the perfect answer. Paolo may retrieve his online European Patient Summary for emergency access that is retrieved, transformed into an IPS and shown its content translated in English.
 
 
The GP notes that visual disturbances are a recognized side effect of this medication. No specific treatment is indicated, and Paolo is reassured that side effects will gradually subside, and his GP can prescribe a suitable antihypertensive medication upon his return to Lake Como.
 
The GP notes that visual disturbances are a recognized side effect of this medication. No specific treatment is indicated, and Paolo is reassured that side effects will gradually subside, and his GP can prescribe a suitable antihypertensive medication upon his return to Lake Como.
  
−
=== Diana a pregnant woman  ===
+
=== IPS Storyboard 3: Diana, a pregnant woman  ===
−
Diana is a 34-year-old pregnant woman from Lisbon with a past medical history of allergic asthma and thyroid cancer during adolescence; for the latter she had a surgical procedure done (thyroidectomy) and, as a consequence, suffers hypothyroidism which requires hormone replacement for life (levothyroxine). At the age of 31 she was diagnosed with a hereditary cardiac disorder - Brugada Syndrome- and had a cardioverter defibrillator implanted to control potentially lethal arrhythmias.
+
Diana is a 34-year-old pregnant woman from Lisbon with a past medical history of allergic asthma and thyroid cancer during adolescence; for the latter she had a surgical procedure done (thyroidectomy) and, as a consequence, suffers hypothyroidism which requires hormone replacement for life (levothyroxine). At the age of 31 she was diagnosed with a hereditary cardiac disorder – Brugada Syndrome – and had a cardioverter defibrillator implanted to control potentially lethal arrhythmias.
−
During the pregnancy of her first child (C-section delivery), she suffered gestational diabetes that developed into type 2 diabetes after giving birth and needs now to receive subcutaneous insulin. As chronic treatment she also needs nebulizations three-time per day  for her asthma - this condition is condition is aggravated in her case by being a smoker (1 pack per day) as included in the Social History Section.
+
 
 +
During the pregnancy of her first child (C-section delivery), she suffered gestational diabetes that developed into type 2 diabetes after giving birth and needs now to receive subcutaneous insulin. As chronic treatment she also needs nebulizations three-time per day  for her asthma - this condition is aggravated in her case by being a smoker (1 pack per day) as included in the Social History Section.
 +
 
 
At this moment, she presents severe pre-eclampsia (hypertension during pregnancy) in treatment with two oral antihypertensive agents (a combination medication). Additionally, she is following a 14-day-course of antibiotic treatment due to an acute pyelonephritis (kidney infection more likely to be develop in pregnant women due to the physiological changes that may interfere with the flow of urine).
 
At this moment, she presents severe pre-eclampsia (hypertension during pregnancy) in treatment with two oral antihypertensive agents (a combination medication). Additionally, she is following a 14-day-course of antibiotic treatment due to an acute pyelonephritis (kidney infection more likely to be develop in pregnant women due to the physiological changes that may interfere with the flow of urine).
 +
 
Other sections of her Summary include allergies to latex and kiwi (which are very often associated) and to aspirin, and intolerance to lactose; immunizations administered during childhood and adolescence are also present.
 
Other sections of her Summary include allergies to latex and kiwi (which are very often associated) and to aspirin, and intolerance to lactose; immunizations administered during childhood and adolescence are also present.
 +
 
Although being real choices for the different diseases and conditions, the selection of the patient's current medication tries to present some easily described medication as well as not so easily ones: e.g. insulin degludec, amoxicilin+clavulanic acid, and the combination of ipratropium bromide+salbutamol for nebulization. For the oral treatment of the pre-eclampsia the agents selected would not be used in real practice during pregnancy.
 
Although being real choices for the different diseases and conditions, the selection of the patient's current medication tries to present some easily described medication as well as not so easily ones: e.g. insulin degludec, amoxicilin+clavulanic acid, and the combination of ipratropium bromide+salbutamol for nebulization. For the oral treatment of the pre-eclampsia the agents selected would not be used in real practice during pregnancy.
  
 
==Integrated examples==
 
==Integrated examples==
−
The IPS specification releases are published at [http://ips.art-decor.org Project Publication Page]. The actual release has a link to the XML materials as which the W3C schemas are part of; it also includes example CDA document instances. A set of use cases have been defined and represented in IPS format. Also multiple languages are covered.
+
The IPS specification releases are published at hl7intl.art-decor.org the International Patient Summary Project Publication Page <ref name="ipspubpage">International Patient Summary Project Publication Page http://hl7intl.art-decor.org/index.php?prefix=hl7ips-</ref>. The actual release has a link to the XML materials that the W3C schemas are part of; it also includes example CDA document instances. A set of use cases have been defined and represented in IPS format. Also multiple languages are covered.
−
 
 
−
It is likely that the publication site will move to hl7.org permanently, we will inform about that process.
 
  
−
(a set of link with explanations)
+
It is likely that the publication site will move to hl7.org permanently, and we will inform the community about that process.
−
{{Responsible|Stephen Chu, Giorgio Cangioli (Translation), Kai Heitmann (Translation)}}
 
−
Plan:
 
−
* Create one or more storyboards (Stephen?)
 
−
* Turn the storyboards into real IPS example CDA instances
 
−
* Allow for multilingual CDA (Italian, German)
 
  
 
==Validation artifacts ==
 
==Validation artifacts ==
 
You can test your implementation (instances) against the IPS specification. To download materials to your computer for local testing and validation consider...
 
You can test your implementation (instances) against the IPS specification. To download materials to your computer for local testing and validation consider...
−
* ...the W3C schemas (actually valid for any CDA specification) located at the [http://ips.art-decor.org Project Publication Page]. The actual release has a link to the XML materials as which the W3C schemas are part of; it also includes example CDA document instances.
+
* ...the W3C schemas (actually valid for any CDA specification) located at the Publication Page<ref name="ipspubpage"></ref>. The actual release has a link to the XML materials as which the W3C schemas are part of; it also includes example CDA document instances.
 
* ..the ISO schematron, automatically generated by the tool. These are files to do validation locally by associating IPS CDA instances with the main schematron using an XML editor or to use the derived XSLT conversions and apply the according XSLT derivation to your local IPS CDA instance.
 
* ..the ISO schematron, automatically generated by the tool. These are files to do validation locally by associating IPS CDA instances with the main schematron using an XML editor or to use the derived XSLT conversions and apply the according XSLT derivation to your local IPS CDA instance.
  
Line 105: Line 110:
 
==Operational information ==
 
==Operational information ==
 
* The IPS project has an official mailing list address ips(at)lists.hl7.org, hosted at the HL7 listserver. Visit your [http://www.hl7.org/myhl7/managelistservs.cfm?ref=common Listserv Subscriptions] at hl7.org and subscribe to the '''International Patient Summary (IPS)''' that is summarised under the Structured Documents Work Group.
 
* The IPS project has an official mailing list address ips(at)lists.hl7.org, hosted at the HL7 listserver. Visit your [http://www.hl7.org/myhl7/managelistservs.cfm?ref=common Listserv Subscriptions] at hl7.org and subscribe to the '''International Patient Summary (IPS)''' that is summarised under the Structured Documents Work Group.
−
* We also offer to write an email to ''info(at)international-patient-summary.net'' for inquiries regarding the specification
+
* The original specification is hosted on the logical ART-DECOR main server art-decor.org under the ''Governance Group'' '''HL7 International''', the project is reachable at the [http://art-decor.org/art-decor/decor-project--hl7ips- Live Project Landing Page].
−
* The original specification is hosted on one of the ART-DECOR main servers, the project is reachable at the [http://art-decor.org/art-decor/decor-project--hl7ips- Live Project Landing Page].
+
* Any IPS specification release in HTML format resides at the Publication Page<ref name="ipspubpage"></ref>. It is likely that the publication site will move to hl7.org permanently, we will inform about that process.
−
* Any IPS specification release in HTML format resides at [http://ips.art-decor.org Project Publication Page]. It is likely that the publication site will move to hl7.org permanently, we will inform about that process.
 
 
* The IPS specification on the wiki is hosted here (international-patient-summary.net). It is likely that the publication site will move to hl7.org permanently, we will inform about that process.
 
* The IPS specification on the wiki is hosted here (international-patient-summary.net). It is likely that the publication site will move to hl7.org permanently, we will inform about that process.
  
Line 113: Line 117:
 
Following is a non-exhaustive list of third-party terminologies that may require a separate license:
 
Following is a non-exhaustive list of third-party terminologies that may require a separate license:
 
*'''SNOMED CT''': SNOMED International (formerly know as International Healthcare Terminology Standards Development Organization IHTSDO)<ref>Get SNOMED CT http://www.ihtsdo.org/snomed-ct/get-snomed-ct</ref> or info@ihtsdo.org
 
*'''SNOMED CT''': SNOMED International (formerly know as International Healthcare Terminology Standards Development Organization IHTSDO)<ref>Get SNOMED CT http://www.ihtsdo.org/snomed-ct/get-snomed-ct</ref> or info@ihtsdo.org
−
*'''Logical Observation Identifiers Names & Codes''' (LOINC): The Regenstrief Institute, Inc.
+
*'''Logical Observation Identifiers Names & Codes''' (LOINC): This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core, LOINC Panels and Forms File, LOINC Answer File, LOINC Part File, LOINC Group File, LOINC Document Ontology File, LOINC Hierarchies, LOINC Linguistic Variants File, LOINC/RSNA Radiology Playbook, and LOINC/IEEE Medical Device Code Mapping Table are copyright © 1995-2017, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.
 
*'''Unified Code for Units of Measure (UCUM) : Regenstrief Institute, Inc. and the UCUM Organization  
 
*'''Unified Code for Units of Measure (UCUM) : Regenstrief Institute, Inc. and the UCUM Organization  
 
*'''EDQM Standard Terms ''' : European Directorate for the Quality of Medicines & Healthcare (EDQM) <ref>EDQM Standard Terms https://standardterms.edqm.eu</ref>
 
*'''EDQM Standard Terms ''' : European Directorate for the Quality of Medicines & Healthcare (EDQM) <ref>EDQM Standard Terms https://standardterms.edqm.eu</ref>

Latest revision as of 16:24, 17 December 2017

Appendix (Informative)

Acronyms and abbreviations

  • CCD: Continuity of Care Document
  • C-CDA: Consolidated CDA
  • CDA: Clinical Document Architecture
  • CEN: Comité Européen de Normalisation (European Committee for Standardization)
  • CEN/TC 251 : CEN Technical Committe 251
  • DSTU: Draft Standard for Trial Use
  • EC: European Commission
  • EDQM: European Directorate for the Quality of Medicines & Healthcare
  • eHDSI: Digital Service Infrastructure for eHealth
  • eHN: eHealth Network
  • EHR: Electronic Healthcare Record
  • EN: European Normative [or Standard] (CEN)
  • epSOS: European Patient Smart Open Services
  • EU: European; Europe
  • FDA: Food and Drug Administration (USA)
  • GP: General Practitioner
  • HL7: Health Level Seven
  • HP: Healthcare Professional
  • IDMP: IDentification of Medicinal Products (ISO Standard)
  • IHE: Integrating the Healthcare Enterprise
  • INTERPAS: International Patient Summary (HL7 International Project)
  • IPS: International Patient Summary
  • ISO: International Organization for Standardization
  • JAseHN: Joint Action to Support the eHealth Network
  • JIC: Joint Initiative Council on SDO Global Health Informatics Standardization
  • LOINC: Logical Observation Identifiers Names & Codes
  • MOU: Memorandum of Understanding (on cooperation surrounding health related information and communication technologies, that between EU and US)
  • MPID: Medicinal Product Identifier
  • ONC: Office of the National Coordinator for Health Information Technology (USA)
  • PCC: Patient Care Coordination
  • PCID : Medicinal Product Package Identifier
  • PhPID(s): Pharmaceutical Product Identifier(s)
  • prEN: Draft European Normative [or Standard] (CEN)
  • prTS: Draft Technical Specifications (CEN)
  • PS: Patient Summary
  • S&I: Standards and Interoperability (S&I) Framework (run by ONC)
  • SAIF: Service Aware Interoperability Framework
  • SDO: Standards Developing Organization
  • STU: Standard for Trial Use
  • TS: Technical Specifications (CEN)
  • UCUM: Unified Code for Units of Measure
  • WHO: World Health Organization

Glossary

  • Compliance. A standard or specification is compliant with another standard or specification if all propositions that are true in the initial standard are also true in the complying standard. The target artifact is compliant with the source artifact if and only if all conforming implementations of the target are also conforming with the source (RM-ODP). The term compliance is also used to state expectations as to how certain specifications need to satisfy possible legislative or regulatory constraints or requirements.
  • Conformance relates an implementation to a standard. Any proposition that is true of the specification must be true in its implementation. (ISO, 2010).
  • Conformance Assessment is a process whereby a given implementation instance is evaluated to determine which of its various Conformance Assertions are valid implementations of a given specification’s Conformance Statements.
  • Conformance Statement is a statement that identifies testable requirements at a specified Conformance Point within a specification, explicitly defining the behavior which must be satisfied at these points. Conformance Statements will only occur in standard which are intended to constrain some feature of a real implementation, so that there exists, in principle, the possibility of testing.
  • Conformance Assertion is a testable, verifiable statement made about a specific implementation instance against a corresponding Conformance Statement.
  • Conformance Points are the evaluation of conformance at specific points in the implementation or specification. See Conformance.
  • Electronic Patient Summary: electronic health record extract containing essential healthcare information intended for specific uses . (EN ISO 13940: 2016)
  • International Patient Summary : electronic patient summary for use in the unscheduled, cross-border care scenario comprising at least the required elements of the IPS dataset.
  • International Patient Summary dataset: a minimal and non-exhaustive patient summary dataset, specialty-agnostic, condition-independent, but readily usable by clinicians for the cross-border unscheduled care of a patient.

Real World User Stories

This section reports a series of real world user stories adapted from the Trillium Bridge project [1] and the eHDSI initiative [2].

IPS Storyboard 1: Martha, a traveling corporate executive

Martha, a 45-year old corporate executive and breast cancer survivor travels frequently on business between the US and EU countries. She carries a clinical summary on her mobile phone and on paper just in case she needs to seek medical care regarding recurring symptoms. Martha’s summary includes

  • Breast cancer Stage II with no evidence of recurrence following treatment
  • hot flashes as problems
  • Anastrozole 1 mg. once daily
  • Black Cohosh Extract herbal supplement as medications
  • the indication of an allergy to Penicillin
  • and finally as Plan of Care, to continue hormone medication with Anastrozole for total of 5 years
  • and monitor for potential breast cancer recurrence.

During a visit in Austria, Martha walks up a hill and experiences shortness of breath, faints, and wakes up a few minutes later after hitting her head on a stone step. A passerby helps her get to the emergency department of a local hospital. An ambulance is called and she is brought to the emergency ward.

During registration and admission, Martha hands in her patient summary in a USB key. At the hospital, Martha is evaluated by an oncologist and a cardiologist.

Following care provision, Martha receives an encounter report. When back home she hands in the encounter report to her primary physician, who updates her record.

IPS Storyboard 2: Paolo, a retired businessman

Paolo Cerruti is a 67-year-old retired businessman, who normally lives in the outskirts Bergamo, near Lake Como, in Lombardy. He is generally healthy, but has long-standing hypertension. His regular physician changed his medication two weeks ago because of poor blood pressure control on his previous medication. He is on holiday going through New England, US, travelling on his own to enjoy the autumn foliage, and is presently in Boston, MA. He is nearing the end of his holiday, and will be returning to Italy in three days’ time. Two days ago he lost his day bag. The bag included his hypertension medication, and he has not been able to take his tablets for two days.

This morning he has woken up feeling dizzy and has blurred vision. The hotel is able to put him in urgent contact with a local general practitioner (GP). Having assessed him, the GP noted a raised blood pressure, but is uncertain about whether to attribute these symptoms to the raised blood pressure or a side effect of the new medication. Now, the GP in Boston needs to know the medication, and the past few blood pressure readings to determine how exceptional the present reading is and manage Paolo appropriately.

Immediate access to his International Patient Summary would be the perfect answer. Paolo may retrieve his online European Patient Summary for emergency access that is retrieved, transformed into an IPS and shown its content translated in English.

The GP notes that visual disturbances are a recognized side effect of this medication. No specific treatment is indicated, and Paolo is reassured that side effects will gradually subside, and his GP can prescribe a suitable antihypertensive medication upon his return to Lake Como.

IPS Storyboard 3: Diana, a pregnant woman

Diana is a 34-year-old pregnant woman from Lisbon with a past medical history of allergic asthma and thyroid cancer during adolescence; for the latter she had a surgical procedure done (thyroidectomy) and, as a consequence, suffers hypothyroidism which requires hormone replacement for life (levothyroxine). At the age of 31 she was diagnosed with a hereditary cardiac disorder – Brugada Syndrome – and had a cardioverter defibrillator implanted to control potentially lethal arrhythmias.

During the pregnancy of her first child (C-section delivery), she suffered gestational diabetes that developed into type 2 diabetes after giving birth and needs now to receive subcutaneous insulin. As chronic treatment she also needs nebulizations three-time per day for her asthma - this condition is aggravated in her case by being a smoker (1 pack per day) as included in the Social History Section.

At this moment, she presents severe pre-eclampsia (hypertension during pregnancy) in treatment with two oral antihypertensive agents (a combination medication). Additionally, she is following a 14-day-course of antibiotic treatment due to an acute pyelonephritis (kidney infection more likely to be develop in pregnant women due to the physiological changes that may interfere with the flow of urine).

Other sections of her Summary include allergies to latex and kiwi (which are very often associated) and to aspirin, and intolerance to lactose; immunizations administered during childhood and adolescence are also present.

Although being real choices for the different diseases and conditions, the selection of the patient's current medication tries to present some easily described medication as well as not so easily ones: e.g. insulin degludec, amoxicilin+clavulanic acid, and the combination of ipratropium bromide+salbutamol for nebulization. For the oral treatment of the pre-eclampsia the agents selected would not be used in real practice during pregnancy.

Integrated examples

The IPS specification releases are published at hl7intl.art-decor.org the International Patient Summary Project Publication Page [3]. The actual release has a link to the XML materials that the W3C schemas are part of; it also includes example CDA document instances. A set of use cases have been defined and represented in IPS format. Also multiple languages are covered.

It is likely that the publication site will move to hl7.org permanently, and we will inform the community about that process.

Validation artifacts

You can test your implementation (instances) against the IPS specification. To download materials to your computer for local testing and validation consider...

  • ...the W3C schemas (actually valid for any CDA specification) located at the Publication Page[3]. The actual release has a link to the XML materials as which the W3C schemas are part of; it also includes example CDA document instances.
  • ..the ISO schematron, automatically generated by the tool. These are files to do validation locally by associating IPS CDA instances with the main schematron using an XML editor or to use the derived XSLT conversions and apply the according XSLT derivation to your local IPS CDA instance.

For further information you can follow the documentation.

Operational information

  • The IPS project has an official mailing list address ips(at)lists.hl7.org, hosted at the HL7 listserver. Visit your Listserv Subscriptions at hl7.org and subscribe to the International Patient Summary (IPS) that is summarised under the Structured Documents Work Group.
  • The original specification is hosted on the logical ART-DECOR main server art-decor.org under the Governance Group HL7 International, the project is reachable at the Live Project Landing Page.
  • Any IPS specification release in HTML format resides at the Publication Page[3]. It is likely that the publication site will move to hl7.org permanently, we will inform about that process.
  • The IPS specification on the wiki is hosted here (international-patient-summary.net). It is likely that the publication site will move to hl7.org permanently, we will inform about that process.

Licenses

Following is a non-exhaustive list of third-party terminologies that may require a separate license:

  • SNOMED CT: SNOMED International (formerly know as International Healthcare Terminology Standards Development Organization IHTSDO)[4] or info@ihtsdo.org
  • Logical Observation Identifiers Names & Codes (LOINC): This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core, LOINC Panels and Forms File, LOINC Answer File, LOINC Part File, LOINC Group File, LOINC Document Ontology File, LOINC Hierarchies, LOINC Linguistic Variants File, LOINC/RSNA Radiology Playbook, and LOINC/IEEE Medical Device Code Mapping Table are copyright © 1995-2017, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.
  • Unified Code for Units of Measure (UCUM) : Regenstrief Institute, Inc. and the UCUM Organization
  • EDQM Standard Terms  : European Directorate for the Quality of Medicines & Healthcare (EDQM) [5]

FAQ’s

This is a placeholder for future Frequently Asked Questions about the International Patient Summary.

  1. ↑ The Trillium Bridge Project http://www.trilliumbridge.eu
  2. ↑ The eHDSI initiative https://ec.europa.eu/cefdigital/wiki/display/EHOPERATIONS/eHealth+DSI+Operations+Home
  3. ↑ 3.0 3.1 3.2 International Patient Summary Project Publication Page http://hl7intl.art-decor.org/index.php?prefix=hl7ips-
  4. ↑ Get SNOMED CT http://www.ihtsdo.org/snomed-ct/get-snomed-ct
  5. ↑ EDQM Standard Terms https://standardterms.edqm.eu
Retrieved from "http://wiki.international-patient-summary.net/index.php?title=IPS_Appendix_1&oldid=4333"